These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 13529830)

  • 1. Changes in enzyme activity (glutamic oxaloacetic transaminase, lactic dehydrogenase, cytochrome c, and cytochrome oxidase) in serum and heart muscle after experimental myocardial infarction in the dog.
    REDETZKI H; RUSKIN A; NOWINSKI W; SINCLAIR JG; ROSENTHAL P; RUSKIN B
    Tex Rep Biol Med; 1958; 16(1):101-15. PubMed ID: 13529830
    [No Abstract]   [Full Text] [Related]  

  • 2. Alterations in the serum activity of some myocardial enzymes in heart disease; significance of serum glutamic oxaloacetic transaminase, serum glutamic pyruvic transaminase, and lactic dehydrogenase activity in heart disease.
    LA DUE JS
    Geriatrics; 1957 Sep; 12(9):528-34. PubMed ID: 13462115
    [No Abstract]   [Full Text] [Related]  

  • 3. Ensymatic changes in acute myocardial ischemic injury; glutamic oxaloacetic transaminase, lactic dehydrogenase, and succinic dehydrogenase.
    JENNINGS RB; KALTENBACH JP; SMETTERS GW
    AMA Arch Pathol; 1957 Jul; 64(1):10-6. PubMed ID: 13434563
    [No Abstract]   [Full Text] [Related]  

  • 4. Glutamic-oxalacetic transaminase in the diagnosis of myocardial infarction. II. Comparison of serum transaminase activity with determinations of serum aldolase, cholesterol, alpha2-globulin, iron, copper and lactic dehydrogenase.
    HANSON A; BIORCK G
    Acta Med Scand; 1957 Jun; 157(6):493-502. PubMed ID: 13434796
    [No Abstract]   [Full Text] [Related]  

  • 5. Glutamic-oxalacetic transaminase and lactic dehydrogenase in serum and cerebrospinal fluid of patients with neurologic disorders.
    FLEISHER GA; WAKIM KG; GOLDSTEIN NP
    Proc Staff Meet Mayo Clin; 1957 Apr; 32(8):188-97. PubMed ID: 13420177
    [No Abstract]   [Full Text] [Related]  

  • 6. [Cytochromes and cytochrome-oxidase activity of isoniazid-sensitive and isoniazid-resistant Mycobacteria].
    ANDREJEW A; GERNEZ-RIEUX C; TACQUET A
    Ann Inst Pasteur (Paris); 1957 Sep; 93(3):281-8. PubMed ID: 13470449
    [No Abstract]   [Full Text] [Related]  

  • 7. Lactic dehydrogenase and glutamic oxaloacetic transaminase in normal pregnant women and newborn children.
    WEST M; ZIMMERMAN HJ
    Am J Med Sci; 1958 Apr; 235(4):443-7. PubMed ID: 13520729
    [No Abstract]   [Full Text] [Related]  

  • 8. Effect of dehydrogenase and cytochrome oxidase enzyme systems on the activity of spermatozoa.
    SEMAKOV VG
    Biokhimiia; 1962; 26():556-9. PubMed ID: 14039127
    [No Abstract]   [Full Text] [Related]  

  • 9. [The effect of the dehydrogenase and cytochrome oxidase enzyme systems on vital activity of spermatozoa].
    SEMAKOV VG
    Biokhimiia; 1961; 26():630-4. PubMed ID: 13749984
    [No Abstract]   [Full Text] [Related]  

  • 10. [Enzymatic activity (glutamic oxalacetic transaminase, glutamic pyruvic transaminase & lactic acid dehydrogenase, in alcoholism].
    LINDE S
    Sven Lakartidn; 1959 Jan; 56(1):14-9. PubMed ID: 13625125
    [No Abstract]   [Full Text] [Related]  

  • 11. Enzyme changes induced in normal and malignant tissues with chemical agents. III. Effect of acetylpodophyllotoxin-omega-pyridinium chloride on cytochrome oxidase, cytochrome c, succinoxidase, succinic dehydrogenase, and respiration of sarcoma 37.
    WARAVDEKAR VS; PARADIS AD; LEITER J
    J Natl Cancer Inst; 1953 Dec; 14(3):585-92. PubMed ID: 13233815
    [No Abstract]   [Full Text] [Related]  

  • 12. Serum glutamic oxalo-acetic transaminase and lactic dehydrogenase levels and their clinical significance.
    WOOD JE; ATUK NO; CAMP JL; BECKWITH JR; LOWRANCE PB
    Northwest Med; 1958 Nov; 57(11):1447-51. PubMed ID: 13590568
    [No Abstract]   [Full Text] [Related]  

  • 13. [Serum glutamic oxaloacetic transaminase in myocardial infarct & liver diseases: general review].
    BELANGER M; LESSARD A
    Laval Med; 1958 Jun; 26(1):74-110. PubMed ID: 13564853
    [No Abstract]   [Full Text] [Related]  

  • 14. [Contribution to the diagnosis of myocardial infarct. Note 2. The determination of glutamic-oxalacetic transaminase and lactic dehydrogenase in acute myocardial infarct].
    FONNESU V; MARTINELLI M; SILVESTRI G
    Riforma Med; 1960 May; 74():543-8. PubMed ID: 13700583
    [No Abstract]   [Full Text] [Related]  

  • 15. [The alternative oxidase of Yarrowia lipolytica mitochondria is unable to compete with the cytochrome pathway for electrons].
    Akimenko VK; Arinbasarova AIu; Smirnova NM; Medentsev AG
    Mikrobiologiia; 2003; 72(4):453-8. PubMed ID: 14526532
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Experimental examination of the mechanism of pyramidon effect. 3. Effect of high pyramidon doses on the glutamic acid-oxaloacetic acid transaminase activity in serum.
    FAZEKAS AG; FAZEKAS IG; RENGEI B
    Can J Biochem Physiol; 1960 Aug; 38():899-901. PubMed ID: 13698448
    [No Abstract]   [Full Text] [Related]  

  • 17. Nitric oxide reacts with the ferryl-oxo catalytic intermediate of the CuB-lacking cytochrome bd terminal oxidase.
    Borisov VB; Forte E; Sarti P; Brunori M; Konstantinov AA; Giuffrè A
    FEBS Lett; 2006 Sep; 580(20):4823-6. PubMed ID: 16904110
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [On the behavior of some enzymatic activities of neoplastic tissues (glutamic-oxalacetic transaminases, glutamic-pyruvic transaminases, aldolase, lactic hydrogenase and malic dehydrogenase). I. Breast neoplasms].
    PETRONIO L; AULISA B; PALAMARA F; GIRALDI A
    Arch De Vecchi Anat Patol; 1960 Nov; 34():1-20. PubMed ID: 13734928
    [No Abstract]   [Full Text] [Related]  

  • 19. [Potential of oxidation-reduction in cytochrome B2 preparations with lactic dehydrogenase activity].
    BOERI E; CUTOLO E
    Boll Soc Ital Biol Sper; 1957; 33(10-11):1711-4. PubMed ID: 13546415
    [No Abstract]   [Full Text] [Related]  

  • 20. Activity of glutamic-oxaloacetic transaminase in the serum in the neonatal period.
    KOVE S; GOLDSTEIN S; WROBLEWSKI F
    Pediatrics; 1957 Oct; 20(4):584-9. PubMed ID: 13484299
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.